Financials

Company Profile

IMV Inc. is a Canada-based company. The Company has sold all of its assets. It is not engaged in any business operations.

Employees

Sector

24-04-24	OPEC excited about Namibia partnership, offers support	RE
23-03-16	IMV Inc., Q4 2022 Earnings Call, Mar 16, 2023
22-11-11	IMV Inc., Q3 2022 Earnings Call, Nov 11, 2022
22-08-11	IMV Inc., Q2 2022 Earnings Call, Aug 11, 2022
22-06-29	IMV Inc. - Shareholder/Analyst Call

23-09-04	IMV Accepts an Offer from its Secured Lenders for the Sale of its Intellectual Property Assets	AQ
19-06-13	IMV Inc. : to Present at Two Upcoming Investor Conferences	BU
19-06-12	Imv : New Phase 2 Clinical Trial Results Continue to Demonstrate Potential Clinical Benefit of IMV’s DPX-Survivac in Combination with Merck’s Keytruda in Patients with DLBCL	BU

Manager	Title	Age	Since
Stéphane Fiset CTO	Chief Tech/Sci/R&D Officer	-	-
Tracy Sherren SEC	Corporate Secretary	60	-
Marie-Eve Charrois LAW	General Counsel	-	-

Director	Title	Age	Since
Markus Warmuth BRD	Director/Board Member	55	2018-11-05
Michael Bailey CHM	Chairman	60	2022-04-30
Michael Kalos BRD	Director/Board Member	64	2021-05-10

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
IMV INC	-2.08%	+4.96%	-	-	14
CHURCHILL CAPITAL CORP VII	-0.30%	-.--%	-.--%	-3.01%	915M
CENTIEL AG	-0.94%	+6.03%	+422.92%	-57.59%	848M
EINRIDE AB	+13.54%	-26.35%	-	-	975M
PRIME BEING CORP.	-35.29%	0.00%	+44.74%	+391.07%	797M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	+0.20%	0.00%	-	-	643M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	-.--%	-.--%	-.--%	600M
BAIN CAPITAL GSS INVESTMENT CORP.	+0.10%	+0.69%	-	-	600M
CANTOR EQUITY PARTNERS IV, INC.	+0.39%	-0.19%	-	-	592M
CHURCHILL CAPITAL CORP XI	+15.07%	+16.13%	-	-	668M
Average	-0.93%	-0.41%	+116.92%	+82.62%	737.56M
Weighted average by Cap.	-0.83%	-1.43%	+124.80%	+82.30%